Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
Blood Advances|January 25, 2023
Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trialPeter W M Johnson, Sriram Balasubramanian, Brendan Hodkinson, et al.British Journal of Haematology|November 29, 2020
Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordanceSophia Ahmed, Paul Glover, Jan Taylor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma TrialStefano Luminari, Alexander Fossa, Judith Trotman, et al.Blood|November 15, 2013
Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificityAndrew T Vaughan, Chisako Iriyama, Stephen A Beers, et al.Oncogene|May 4, 2004
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavageJorg Michels, Jason W O'Neill, Claire L Dallman, et al.Blood|December 17, 2008
Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapyTim M Illidge, Mike Bayne, Nicholas S Brown, et al.Nature Cancer|March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.Oncogene|August 7, 2003
The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcriptionRamsey I Cutress, Paul A Townsend, Adam Sharp, et al.British Journal of Haematology|May 10, 2017
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 studyLuca Ceriani, Maurizio Martelli, Annarita Conconi, et al.Blood|March 8, 2011
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignanciesWaleed Alduaij, Andrei Ivanov, Jamie Honeychurch, et al.Pageof 11